Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Micafungin Versus AmBisome in Invasive Candidiasis and Candidemia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Astellas Pharma Inc
ClinicalTrials.gov Identifier:
NCT00106288
First received: March 22, 2005
Last updated: September 17, 2014
Last verified: September 2014